for a number of reasons, such as keeping FT Sites reliable and secure,
personalising content and ads, providing social media features and to
analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Jeremy Farrar says further virus mutations that reduce jab efficacy should be expected
Medical charity’s endowment boosted investments in research, much of it tied to pandemic
Its effects are rippling out in circles like a stone thrown into a pond. But they can be stopped
Business can play a powerful role in funding the pandemic’s only viable exit strategy